Investopedia: Roche Delivering Leverage, But Needs Diversification

These remain good days for Swiss drug and diagnostics giant Roche (Nasdaq: RHHBY ), as the company continues to see double-digit growth ac...

Investopedia: Alnylam Basking In Orphan Drug Attention

It's been a pretty wild ride for Alnylam (Nasdaq: ALNY ) shareholders, even by the elevated standards of biotechnology. Once thought t...